Literature DB >> 19229049

Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels.

Ana I Antón1, Raúl Teruel, Javier Corral, Antonia Miñano, Irene Martínez-Martínez, Adriana Ordóñez, Vicente Vicente, Beatriz Sánchez-Vega.   

Abstract

Genetic factors involved in the interindividual variability of antithrombin have not been identified. We studied two polymorphisms of the gene coding for antithrombin (SER-PINC1) in 298 Spanish Caucasian blood donors: rs3138521, a DNA length polymorphism located on the promoter region and rs2227589, a SNP located on intron 1 that has been described as a mild thrombotic risk factor. We detected a complete linkage disequilibrium between these polymorphisms (D'=0.999). The rs3138521 polymorphism has no functional consequences. However, the rs2227589 SNP significantly associated with plasma anti-FXa activity and antithrombin levels: carriers of the A allele had slightly but significantly lower anticoagulant activity and levels than GG subjects (97.0+/-7.3% vs. 94.6+/-8.4%; p=0.032; 99.5+/-5.8% vs. 94.8+/-5.6%; p=0.001; respectively). Our results identified a functional effect of the rs2227589 polymorphism not explained by its linkage with the promoter polymorphism that support the moderate thrombotic risk associated with the A allele.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19229049      PMCID: PMC2663624          DOI: 10.3324/haematol.2008.000604

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  19 in total

1.  Genetic determinants of hemostasis phenotypes in Spanish families.

Authors:  J C Souto; L Almasy; M Borrell; M Garí; E Martínez; J Mateo; W H Stone; J Blangero; J Fontcuberta
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

2.  DNA length polymorphism present in the antithrombin III promoter region does not influence plasma antithrombin III activity levels.

Authors:  R W Niessen; R J Lamping; A Sturk; M Peters
Journal:  Thromb Haemost       Date:  1996-02       Impact factor: 5.249

3.  Ligand-dependent enhancement of human antithrombin gene expression by retinoid X receptor alpha and thyroid hormone receptor beta.

Authors:  R W Niessen; F Rezaee; P H Reitsma; M Peters; J J de Vijlder; A Sturk
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

4.  Complete antithrombin deficiency in mice results in embryonic lethality.

Authors:  K Ishiguro; T Kojima; K Kadomatsu; Y Nakayama; A Takagi; M Suzuki; N Takeda; M Ito; K Yamamoto; T Matsushita; K Kusugami; T Muramatsu; H Saito
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

5.  Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Authors:  M G Conlan; A R Folsom; A Finch; C E Davis; G Marcucci; P Sorlie; K K Wu
Journal:  Thromb Haemost       Date:  1994-10       Impact factor: 5.249

6.  Interactions between genotype and phenotype in bleeding and thrombosis.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2008-05       Impact factor: 9.941

7.  Gene variants associated with deep vein thrombosis.

Authors:  Irene D Bezemer; Lance A Bare; Carine J M Doggen; Andre R Arellano; Carmen Tong; Charles M Rowland; Joseph Catanese; Bradford A Young; Pieter H Reitsma; James J Devlin; Frits R Rosendaal
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

8.  Characterization of an unusual DNA length polymorphism 5' to the human antithrombin III gene.

Authors:  S C Bock; D J Levitan
Journal:  Nucleic Acids Res       Date:  1983-12-20       Impact factor: 16.971

9.  Influence of demographic factors on antithrombin III activity in a healthy population.

Authors:  R C Tait; I D Walker; S I Islam; F McCall; J A Conkie; R Mitchell; J F Davidson
Journal:  Br J Haematol       Date:  1993-07       Impact factor: 6.998

Review 10.  Past and future of genetic research in thrombosis.

Authors:  P H Reitsma; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

View more
  9 in total

1.  Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case-control study in Indian population.

Authors:  Amit Sharma; Teena Bhakuni; Ravi Ranjan; Ravi Kumar; Kamal Kishor; Vineet Kumar Kamal; Manoranjan Mahapatra; Mohamad Aman Jairajpuri; Renu Saxena
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

2.  New gene variants associated with venous thrombosis: a replication study in White and Black Americans.

Authors:  H Austin; C De Staercke; C Lally; I D Bezemer; F R Rosendaal; W C Hooper
Journal:  J Thromb Haemost       Date:  2011-03       Impact factor: 5.824

3.  Primary myelofibrosis with thrombophilia as first symptom combined with thalassemia and Gilbert syndrome: A case report.

Authors:  Guzailinuer Wufuer; Kaisaer Wufuer; Tu Ba; Tao Cui; Ling Tao; Ling Fu; Ming Mao; Ming-Hui Duan
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

4.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

5.  Antithrombin III deficiency in Indian patients with deep vein thrombosis: identification of first India based AT variants including a novel point mutation (T280A) that leads to aggregation.

Authors:  Teena Bhakuni; Amit Sharma; Qudsia Rashid; Charu Kapil; Renu Saxena; Manoranjan Mahapatra; Mohamad Aman Jairajpuri
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

6.  Association of SERPINC1 Gene Polymorphism (rs2227589) With Pulmonary Embolism Risk in a Chinese Population.

Authors:  Yongjian Yue; Qing Sun; Lu Xiao; Shengguo Liu; Qijun Huang; Minlian Wang; Mei Huo; Mo Yang; Yingyun Fu
Journal:  Front Genet       Date:  2019-09-13       Impact factor: 4.599

7.  Patients with SERPINC1 rs2227589 polymorphism found to have multiple cerebral venous sinus thromboses despite a normal antithrombin level: A case report.

Authors:  Feng Liao; Jun-Ling Zeng; Jian-Gang Pan; Jing Ma; Zhi-Jian Zhang; Zhi-Jun Lin; Li-Feng Lin; Yu-Sen Chen; Xiao-Tang Ma
Journal:  World J Clin Cases       Date:  2022-01-14       Impact factor: 1.337

8.  Identification of antithrombin-modulating genes. Role of LARGE, a gene encoding a bifunctional glycosyltransferase, in the secretion of proteins?

Authors:  María Eugenia de la Morena-Barrio; Alfonso Buil; Ana Isabel Antón; Irene Martínez-Martínez; Antonia Miñano; Ricardo Gutiérrez-Gallego; José Navarro-Fernández; Sonia Aguila; Juan Carlos Souto; Vicente Vicente; José Manuel Soria; Javier Corral
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

9.  Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency.

Authors:  Mara Toderici; María Eugenia de la Morena-Barrio; José Padilla; Antonia Miñano; Ana Isabel Antón; Juan Antonio Iniesta; María Teresa Herranz; Nuria Fernández; Vicente Vicente; Javier Corral
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.